Welcome to the Journal of Chromatographic Science, a premier publication dedicated to advancing the scientific understanding of chromatographic techniques and their applications across various disciplines. Published by Oxford University Press Inc, this journal, with its ISSN 0021-9665 and E-ISSN 1945-239X, has been disseminating innovative research since 1963, serving as a vital resource for researchers, industry professionals, and academic scholars in the fields of Analytical Chemistry and Medicine. As evidenced by its 2023 Scopus ranking, the journal stands at the Q3 quartile in both its primary disciplines, highlighting its relevance and contribution to ongoing research. The journal promotes high-quality, peer-reviewed articles that aim to foster knowledge and encourage the practical application of chromatographic science. While it operates under a traditional subscription model, the valuable insights it offers are essential for those seeking to enhance their expertise and stay at the forefront of chromatographic methodologies. Join our community of scholars as we explore the complexities and innovations in chromatographic science, paving the way for future discoveries.

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES is a peer-reviewed journal published by Mary Ann Liebert, Inc., focused on the innovative fields of pharmacology and drug development. With its ISSN 1540-658X and E-ISSN 1557-8127, the journal has successfully contributed to the scientific community since its inception in 2002, converging into one comprehensive resource by 2024. Positioned in the Q3 quartile for Drug Discovery and Q4 for Molecular Medicine as per the 2023 rankings, the journal is dedicated to disseminating cutting-edge research that addresses the complexities of drug assay techniques and their implications in therapeutics. Although currently not an open-access publication, it offers significant insights and findings valuable to researchers, professionals, and students in the realm of biochemistry and pharmacology. With a commitment to advancing knowledge and innovation, ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES continues to be an essential platform for the latest advancements in drug discovery and development.

Analytical and Bioanalytical Chemistry Research is an esteemed open-access journal published by the Iranian Chemical Society, dedicated to the advancement of knowledge in the fields of analytical chemistry, biochemistry, and spectroscopy. Since its inception in 2014, this journal has provided a platform for researchers, professionals, and students to publish and access high-quality research articles that contribute to the understanding of chemical analysis and bioanalytical methods. With an ISSN of 2383-093X and an open-access model that promotes global dissemination of findings, it ensures that innovative research reaches a broad audience. The journal has consolidated its presence in the scientific community, currently ranked in quartile Q4 for analytical chemistry, biochemistry, and spectroscopy as of 2023. Its Scopus rankings, including a percentile of 34th in Analytical Chemistry, reflect its commitment to quality research and scholarly contribution. Situated in Tehran, Iran, the journal serves as a vital resource for academic discourse, offering insights into emerging trends and methodologies in analytical and bioanalytical chemistry.

Journal of Mass Spectrometry and Advances in the Clinical Lab, published by Elsevier, serves as a premier resource within the fields of clinical biochemistry, medical laboratory technology, microbiology, and spectroscopy. Launched in 2021 with an Open Access model, this journal enhances the accessibility of innovative research, making it an ideal platform for researchers, practitioners, and students alike. With an impressive impact factor reflected in its quartile rankings—Q2 in Clinical Biochemistry and Microbiology, and Q1 in Medical Laboratory Technology and Spectroscopy—this journal ensures high visibility and credibility. The journal's diverse indexing and significant standings in Scopus rankings highlight its commitment to advancing knowledge and fostering collaboration among professionals in laboratory sciences. Endorsed by a robust editorial board comprising leading experts, the journal aims to disseminate cutting-edge findings and methodologies, contributing to significant advancements in clinical and scientific laboratory practices. By bridging theoretical frameworks and practical applications, this journal plays a crucial role in the continuous evolution of laboratory technologies, thereby empowering readers to push the boundaries of research and innovation in their fields.

ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.

ACTA POLONIAE PHARMACEUTICA is a well-established peer-reviewed journal published by Polskie Towarzystwo Farmaceutyczne, dedicated to the field of pharmaceutical sciences and pharmacology. With a rich history dating back to 1951, this journal serves as a vital platform for disseminating cutting-edge research and developments in pharmaceutical technology, drug development, and therapeutic therapies. Although it currently operates under a subscription model, its commitment to scientific rigor has earned it a respectable impact factor, placing it in the Q3 and Q4 quartiles respectively for Pharmaceutical Science and Pharmacology as of 2023. Researchers and practitioners alike will find value in its comprehensive coverage of essential topics, as well as its diverse range of contributions from both established and emerging scholars in the field. With its address located in the heart of Warsaw, Poland, ACTA POLONIAE PHARMACEUTICA aims to further bridge the gap between academia and industry, paving the way for innovation in drug discovery and therapeutic applications.

Revista Romana de Medicina de Laborator is a prominent open-access journal published by SCIENDO, dedicated to the field of medical laboratory technology and biochemistry. Since its inception, this journal has been a vital platform for disseminating research findings and advancements in laboratory medicine. With an ISSN of 1841-6624 and E-ISSN 2284-5623, it has served the academic community since 2008 and has embraced an open-access model since 2013, ensuring that valuable research is accessible to all. While it features niche rankings in Scopus for areas such as Medical Laboratory Technology and Clinical Biochemistry, it consistently strives to engage researchers, professionals, and students. Its rich collection of articles highlights innovative techniques and methodologies, supporting the ongoing development of laboratory practices. Although its coverage in Scopus has been discontinued, the journal continues to publish high-quality studies that contribute significantly to the field, fostering knowledge exchange essential for advancing medical science.

CHEMICAL RESEARCH IN CHINESE UNIVERSITIES is a prominent academic journal dedicated to the dissemination of high-quality research in the field of chemistry and related educational methodologies. Published by HIGHER EDUCATION PRESS, this journal has established itself as a vital resource for researchers and professionals looking to stay at the forefront of chemical sciences. With an impressive impact factor and ranked in the Q2 quartile for both Chemistry and Education categories, it highlights significant advancements while maintaining rigorous peer-review standards. The journal's ISSN is 1005-9040 and its E-ISSN is 2210-3171, ensuring broad accessibility to its global readership. Although it does not offer open access, its contributions are vital to understanding the dynamics of chemistry research and education within and beyond China. With converged publication years from 1999 through to 2024, CHEMICAL RESEARCH IN CHINESE UNIVERSITIES continues to be an essential platform for innovative studies and critical discussions in the expanding realm of chemistry.

Analytical & Bioanalytical Electrochemistry is a pivotal journal dedicated to the advancement of research and innovation in the fields of analytical chemistry and electrochemistry. Published by the University of Tehran, Faculty of Chemistry, Center of Excellence in Electrochemistry, this journal has been contributing to the scientific community since its inception in 2009 and continues to be a critical platform through 2024. With an ISSN of 2008-4226, it focuses on a variety of topics including electrochemical sensors, bioanalytical techniques, and innovative methodologies in electrochemical analysis. Although it currently holds a Q4 quartile ranking in both analytical chemistry and electrochemistry categories, its unique insights and research findings are essential for advancing knowledge and fostering interdisciplinary collaboration within the scientific community. Researchers, professionals, and students engaged in these dynamic fields will find valuable resources and contribute to the ongoing discourse by publishing their work in this journal. We invite you to explore and engage with the diverse content that Analytical & Bioanalytical Electrochemistry offers to enhance your research and professional development.

ANALYTICAL LETTERS is a reputable journal published by Taylor & Francis Inc, focusing on the dynamic fields of analytical chemistry, biochemistry, and clinical biochemistry. With an ISSN of 0003-2719 and an E-ISSN of 1532-236X, the journal has been a platform for scholarly articles since its inception in 1967, and is set to continue its contribution to the scientific community until 2024. Despite its classification in Q3 across various categories as of 2023, including analytical chemistry and spectroscopy, ANALYTICAL LETTERS maintains a significant impact within its field, evidenced by its moderate rankings within Scopus. This journal serves as a vital resource for researchers and professionals seeking to explore recent advancements in analytical methodologies, instrumentation, and applications, facilitating the dissemination of critical insights in laboratory practices. With access primarily through institutional subscriptions, it remains positioned as a crucial tool for those advancing knowledge and innovation in analytical sciences.